ROMANO KATHRYN
SEC insider (Form 3/4/5 filer). CIK 0001801385. Chief Accounting Officer at Krystal Biotech, Inc. (KRYS). 24 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in PITTSBURGH, PA.
Companies ROMANO KATHRYN has filed insider reports for
- Krystal Biotech, Inc. (KRYS): Officer, Chief Accounting Officer
ROMANO KATHRYN
CIK: 0001801385
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Krystal Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Mar 2, 2026KRYS
Krystal Biotech, Inc.
SaleDirect750 shares at avg. $267.60$201K - Feb 27, 2026KRYS
Krystal Biotech, Inc.
Tax PaymentDirect3.3K shares at avg. $275.64$899K - Feb 27, 2026KRYS
Krystal Biotech, Inc.
Tax PaymentDirect240 shares at avg. $275.64$66K - Feb 27, 2026KRYS
Krystal Biotech, Inc.
AwardDirectRestricted Stock Units
5.4K shares- - Feb 27, 2026KRYS
Krystal Biotech, Inc.
ExerciseDirect550 shares- - Feb 27, 2026KRYS
Krystal Biotech, Inc.
ExerciseDirect7.5K shares- - Feb 27, 2026KRYS
Krystal Biotech, Inc.
AwardDirectStock Option (Right to Buy)
13.6K shares- - Feb 9, 2026KRYS
Krystal Biotech, Inc.
SaleDirect2.8K shares at avg. $272.51$770K - Feb 9, 2026KRYS
Krystal Biotech, Inc.
SaleDirect2K shares at avg. $270.56$541K - Feb 9, 2026KRYS
Krystal Biotech, Inc.
ExerciseDirect12.5K shares at avg. $63.55$794K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 2, 2026 | KRYS Krystal Biotech, Inc. | Sale | 750 | $267.60 | $200,700 | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Tax Payment | 3,262 | $275.64 | $899,138 | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Tax Payment | 240 | $275.64 | $66,154 | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Award Restricted Stock Units | 5,442 | - | - | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Exercise | 550 | - | $0 | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Exercise | 7,500 | - | $0 | Direct |
| Feb 27, 2026 | KRYS Krystal Biotech, Inc. | Award Stock Option (Right to Buy) | 13,575 | - | - | Direct |
| Feb 9, 2026 | KRYS Krystal Biotech, Inc. | Sale | 2,824 | $272.51 | $769,562 | Direct |
| Feb 9, 2026 | KRYS Krystal Biotech, Inc. | Sale | 2,000 | $270.56 | $541,116 | Direct |
| Feb 9, 2026 | KRYS Krystal Biotech, Inc. | Exercise | 12,500 | $63.55 | $794,375 | Direct |
1-10 of 24 transactions